Updated November 12 guidance from the American Cancer Society proposes PSA testing every two years for average-risk men aged 50–69, with earlier discussion from 45 for higher-risk groups. Decisions at 70–74 depend on health; routine screening is not advised from 75, or at 80 and above or with life expectancy below ten years. An elevated PSA is not a cancer diagnosis and may require repeat testing and MRI. Active surveillance for low-risk cancer can reduce overtreatment. Application in Korea requires individual assessment with a clinician.
Back to Health
American Cancer Society updates PSA screening guidance
Consider age, risk and life expectancy; a positive result is not a diagnosis.